Thomas G. Wiggans - Mar 2, 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 03:40 PM
Previous filing
Mar 4, 2022
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (Right to Buy) Award $0 +985K $0.00 985K Mar 2, 2022 Common Stock 985K $6.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to such option vest and become exercisable on the first anniversary of March 1, 2022 and the remaining 3/4th of the shares subject to such option will vest and become exercisable in substantially equal monthly installments on the 1st day of each month thereafter, subject to a continued service relationship.